Large Scale Biology Corporation operates as a product-focused biotechnology company using proprietary technologies to develop and manufacture recombinant biologics. The company’s bio-manufacturing opportunities include vaccines, complex proteins, and follow-on off-patent therapeutics. It focuses on Recombinant Aprotinin, a protease inhibitor used in medical, research, and manufacturing applications; Vaccines for human and animal healthcare, including antiviral and anticancer applications; and follow-on off-patent biologics, including Interferon alpha 2a and 2b; Alpha-galactosidase A for treatment of Fabry disease; and Lysosomal acid lipase for the treatment of Wolman disease and...